|
Image-guided ultrasound ablation for precision targeting of prostate cancer
|
1R01CA230323-01
|
$580,217
|
|
BURDETTE, EVERETTE
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
Womens Interagency HIV Study (WIHS-V)
|
3U01AI035004-25S1
|
$144,370
|
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Genetic and Dietary Interactions in MMR Deficient Colon Tumorigenesis
|
1R01CA222358-01A1
|
$635,306
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Next Generation of HPV and Cervical Cancer Research in HIV+ Women
|
1R01CA230331-01
|
$670,295
|
|
STRICKLER, HOWARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Identification and targeting of pathways separating healthy stem cell aging from malignant transformation
|
1R01CA230756-01
|
$382,013
|
|
WILL, BRITTA
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Effects of Meditative Movement (Qigong/Tai Chi Easy) on Fatigued Breast Cancer Survivors
|
3R01CA182901-04S1
|
$39,254
|
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Improving pathologic nodal staging of resected lung cancer
|
2R01CA172253-06
|
$499,347
|
|
OSAROGIAGBON, RAYMOND
|
BAPTIST MEMORIAL HOSPITAL - TIPTON
|
|
(PQ6)Nuclear receptor mechanisms in circadian disruption induced hepatocarcinogenesis
|
1R01CA230848-01
|
$442,560
|
|
FU, LONING
|
BAYLOR COLLEGE OF MEDICINE
|
|
Risk Stratification for and Early Detection of Liver Cancer
|
1U01CA230997-01
|
$732,726
|
|
KANWAL, FASIHA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Context-Specific Functional Annotation of EGFR Mutations in Glioblastoma
|
5F32CA221015-02
|
$59,038
|
|
KONG, KATHLEEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors
|
3R01CA215452-02S1
|
$7,156
|
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
Targeting aberrant promoter DNA methylation for anticancer therapy
|
1R21CA229727-01
|
$182,700
|
|
SHEN, LANLAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
A New Target for Chromatin Remodeler Defects in Cancer
|
1R35CA231993-01
|
$594,375
|
|
WALKER, CHERYL
|
BAYLOR COLLEGE OF MEDICINE
|
|
A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies
|
3R21CA205106-02S1
|
$77,331
|
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Combined breast MRI/biomarker strategies to identify aggressive biology
|
3U01CA189283-04S1
|
$190,203
|
|
SEEWALDT, VICTORIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Advancing treatment outcomes in malignant glioma by integrating immunotherapy and standard of care using genetically engineered mice that recapitulate molecular feature of human glioma
|
1R01CA229784-01
|
$667,694
|
|
CHAREST, ALAIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Identification of Plasma- and Exosome-Based Protein Biomarkers for Early Detection of Pancreatic Cancer Using SOMAscan Technology
|
1R21CA218960-01A1
|
$228,375
|
|
LIBERMANN, TOWIA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Spectro-Holographic Instrument for Dynamic Sensing of Cancer Progression
|
1R01CA228029-01A1
|
$688,217
|
|
PERELMAN, LEV
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Randomized Trial of a Mammography Decision Aid for Women Aged 75 and Older
|
3R01CA181357-05S1
|
$20,788
|
|
SCHONBERG, MARA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Mechanisms of tumorigenesis in Brg1 mutant lung cancer
|
1R01CA216188-01A1
|
$683,713
|
|
KIM, CARLA
|
BOSTON CHILDREN'S HOSPITAL
|
|
Cancer Biology in the Zebrafish
|
2R01CA103846-16A1
|
$420,375
|
|
ZON, LEONARD
|
BOSTON CHILDREN'S HOSPITAL
|
|
Using Community-Engaged Methods to Design a Tool to Promote Informed Breast Cancer Screening Decisions for Low Literacy Women
|
1K07CA221899-01A1
|
$129,704
|
|
GUNN, CHRISTINE
|
BOSTON MEDICAL CENTER
|
|
Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer
|
1R01CA222170-01A1
|
$559,846
|
|
DENIS, GERALD
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Understanding the mechanisms of immune suppression in lymph node metastases
|
1K22CA230315-01
|
$200,880
|
|
JONES, DENNIS
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Follow-up Study for Causes of Illness in Black Women
|
5R01CA058420-20
|
$1
|
$0
|
Rosenberg, Lynn
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Pathogenesis and Treatment of NUT-Midline Carcinoma
|
2R01CA124633-11A1
|
$340,100
|
|
FRENCH, CHRISTOPHER
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
In Situ characterization and manipulation of tumor immune cell metabolomics using implantable microdevices
|
1R01CA223150-01A1
|
$366,134
|
|
JONAS, OLIVER
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Spatiotemporal delivery of synergistic drug combinations to kidney cancer
|
1R01CA229772-01
|
$360,930
|
|
SABBISETTI, VENKATA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Characterizing a new antibody targeting growth-arrested breast cancer cells
|
1R03CA230840-01
|
$80,000
|
|
HUANG, ALEX
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Mechanisms of lincDUSP Oncogenic Effects in Colon Cancer
|
1R01CA217992-01A1
|
$366,000
|
|
KHALIL, AHMAD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Defining the Super-Enhancer Landscape in Triple Negative Breast Cancer Subtypes
|
5F31CA224809-02
|
$48,883
|
|
WEBB, BRYAN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Hes1-loss promotes dysregulation of epithelial homeostasis and inflammation in a serrated adenocarcinoma model
|
1R01CA222064-01A1
|
$412,584
|
|
ZHOU, LAN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Prostate Cancer Bone Metastasis Biology and Targeting
|
3P01CA098912-14S1
|
$18,678
|
|
CHUNG, LELAND
|
CEDARS-SINAI MEDICAL CENTER
|
|
Prostate Cancer Bone Metastasis Biology and Targeting
|
3P01CA098912-14S2
|
$12,477
|
|
CHUNG, LELAND
|
CEDARS-SINAI MEDICAL CENTER
|
|
A Patient-Centered Approach to Integration of Life Expectancy into Treatment Decision Making for Patients with Genitourinary Malignancy
|
1K08CA230155-01
|
$183,258
|
|
DASKIVICH, TIMOTHY
|
CEDARS-SINAI MEDICAL CENTER
|
|
1/2 Cherokee Nation/Stephenson Cancer Center Collaborative on Cancer Disparities
|
3P20CA202923-04S1
|
$32,990
|
|
KHAN, SOHAIL
|
CHEROKEE NATION
|
|
Targeting the GPC2 oncoprotein with immune-based therapies in neuroblastoma
|
1K08CA230223-01
|
$202,195
|
|
BOSSE, KRISTOPHER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Discovering the genetic basis of neuroblastoma initiation and progression
|
1R03CA230366-01
|
$172,000
|
|
DISKIN, SHARON
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Opportunities for targeted therapies generated by APOBEC3A activity in acute myeloid leukemia
|
1R21CA230065-01
|
$187,050
|
|
WEITZMAN, MATTHEW
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Development of a surrogate liquid biopsy from the aqueous humor in retinoblastoma eyes.
|
1K08CA232344-01
|
$228,758
|
|
BERRY, JESSE
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Targeted Inhibition in Triple Negative Breast Cancer
|
1R21CA229930-01
|
$172,913
|
|
NASSAR, NICOLAS
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
FA pathway activities in the normal and transformed epidermis
|
1R01CA223790-01A1
|
$363,713
|
|
WELLS, SUSANNE
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
A biomarker-driven strategy to guide the use of radiotherapy in non-small cell lung cancer
|
1R37CA222294-01A1
|
$366,000
|
|
ABAZEED, MOHAMED
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Compensatory steroidogenesis mechanisms in castration-resistant prostate cancer
|
3R01CA190289-04S1
|
$89,498
|
|
SHARIFI, NIMA
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Functions and Activities of p53 and Mdm2 in Normal and Cancer Cells
|
1R35CA220526-01A1
|
$873,370
|
|
PRIVES, CAROL
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Development of first-in-class histone acetyltransferase (HAT) activators for precision targeting of epigenetic derangements in lymphoma
|
1R01CA222931-01A1
|
$370,575
|
|
AMENGUAL, JENNIFER
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
CAPRI: Columbia Cancer Training Program for Resident-Investigators
|
1R38CA231577-01
|
$358,020
|
|
CREW, KATHERINE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Increasing breast cancer chemoprevention in the primary care setting
|
3R01CA177995-05S1
|
$167,842
|
|
CREW, KATHERINE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cook For Your Life: Maintaining diet and physical activity changes in Latina breast cancer survivors
|
3R01CA186080-04S1
|
$76,307
|
|
GREENLEE, HEATHER
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
NSD1 Inactivation in Head and Neck Cancer
|
4R00CA212257-03
|
$249,000
|
|
LU, CHAO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
Total relevant funding to Contraception and Reproduction Research for this search: $2,073,979
|